Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where E. van Hoffen is active.

Publication


Featured researches published by E. van Hoffen.


Clinical & Experimental Allergy | 2004

Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges

Suzanne Bolhaar; M. M. Tiemessen; Laurian Zuidmeer; A. van Leeuwen; Karin Hoffmann-Sommergruber; Carla A.F.M. Bruijnzeel-Koomen; Leonie S. Taams; Edward F. Knol; E. van Hoffen; R. van Ree; André C. Knulst

Background The effect of birch‐pollen immunotherapy (IT) on cross‐reactive food allergies is controversial.


Allergy | 2009

A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy

E. van Hoffen; Bert Ruiter; Joyce Faber; Laura M'Rabet; Edward F. Knol; Bernd Stahl; Sertac Arslanoglu; Guido E. Moro; G. Boehm; Johan Garssen

Background:  It has been suggested that human breast milk oligosaccharides play a role in the development of the immune system in infants, and may consequently inhibit the onset of allergy. A specific prebiotic mixture of short‐chain galacto‐oligosaccharides and long‐chain fructo‐oligosaccharides (GOS/FOS) has been shown to reduce the incidence of atopic dermatitis (AD) at 6 months of age in infants at risk for allergy.


Clinical & Experimental Allergy | 2007

Children with peanut allergy recognize predominantly Ara h2 and Ara h6, which remains stable over time

Annebeth E. Flinterman; E. van Hoffen; C.F. den Hartog Jager; S.J. Koppelman; S. G. Pasmans; Maarten O. Hoekstra; C.A.F.M. Bruijnzeel-Koomen; André C. Knulst; Edward F. Knol

Background In peanut‐allergic adults, IgE is mainly directed to Ara h1 and Ara h2. More recently, a role for Ara h6 has been suggested. In contrast to adults, IgE in children can fluctuate over time. Therefore, children may have a more dynamic reactivity to peanut.


Clinical & Experimental Allergy | 2007

Does skin prick test reactivity to purified allergens correlate with clinical severity of peanut allergy

Kim A.B.M. Peeters; Stef J. Koppelman; E. van Hoffen; C.W.H. van der Tas; C.F. den Hartog Jager; A.H. Penninks; Susan L. Hefle; C.A.F.M. Bruijnzeel-Koomen; Edward F. Knol; André C. Knulst

Background Recognition of specific peanut allergens or the diversity of IgE binding to peanut allergens may play a role in the elicitation of severe allergic reactions.


Clinical & Experimental Allergy | 2007

Maintenance of tolerance to cow's milk in atopic individuals is characterized by high levels of specific immunoglobulin G4

Bert Ruiter; Edward F. Knol; R.J.J. van Neerven; Johan Garssen; Carla A.F.M. Bruijnzeel-Koomen; André C. Knulst; E. van Hoffen

Background The central role of specific IgE in cows milk allergy (CMA) is well documented. However, less is known about the function of other immunoglobulin isotypes in allergy and tolerance to cows milk proteins (CMPs).


Clinical & Experimental Allergy | 2008

Cow's milk allergy in adults is rare but severe: both casein and whey proteins are involved

H‐Y. Lam; E. van Hoffen; A. Michelsen; K. Guikers; C. H. W. Van Der Tas; Carla A.F.M. Bruijnzeel-Koomen; André C. Knulst

Background Studies on cows milk allergy (CMA) in adults are scarce. Little is known about the clinical symptoms, eliciting doses (ED), and allergens involved.


International Archives of Allergy and Immunology | 2007

Probiotics Have a Different Immunomodulatory Potential in vitro versus ex vivo upon Oral Administration in Children with Food Allergy

Annebeth E. Flinterman; Edward F. Knol; A.G. van Ieperen-van Dijk; H.M. Timmerman; André C. Knulst; C.A.F.M. Bruijnzeel-Koomen; Suzanne G.M.A. Pasmans; E. van Hoffen

Background: Previous studies suggest that administration of probiotics in vitro can stimulate regulatory and Th1 immune responses. We studied both the in vitro immunological effects of probiotics and the ex vivo immunological effects after oral administration of probiotics in children with food allergy, a Th2-mediated disease. Methods: Thirteen children were enrolled. Probiotics (n = 7) or placebo (n = 6) were orally administered during 3 months. At baseline and after 1 and 3 months, peripheral blood mononuclear cells were stimulated with crude peanut extract, anti-CD3, or anti-CD40 and IL-4 in the presence (in vitro response) or absence (ex vivo response) of probiotics. The proliferation and production of IFN-γ, IL-5, IL-13, IL-10, TNF-α, IL-6 and IgE were analyzed. Sensitization to peanut, cow’s milk and hen’s egg was determined before and after treatment. Results: The in vitro addition of probiotics to peripheral blood mononuclear cell cultures resulted in enhanced proliferation and production of IFN-γ, IL-10 and TNF-α. After oral treatment, proliferation in the presence of probiotics increased, whereas in vitro IgE production decreased in the probiotics group compared to baseline. The ex vivo production of IL-10, TNF-α and IL-6 tended to decrease. Th1 and Th2 cytokines were not altered. Sensitization remained unchanged. Conclusion: Probiotics enhanced the production of Th1 and regulatory cytokines in vitro. Oral administration of probiotics resulted in a slightly decreased ex vivo production of IL-10, TNF-α and IL-6. This indicates that probiotics have a different potential to modulate the immune response in vitro versus ex vivo.


Allergy | 2009

Clinical relevance of sensitization to lupine in peanut-sensitized adults

Kim A.B.M. Peeters; S.J. Koppelman; A.H. Penninks; Ans F.M. Lebens; Carla A.F.M. Bruijnzeel-Koomen; Susan L. Hefle; Steve L. Taylor; E. van Hoffen; André C. Knulst

Background:  The use of lupine in food has been increasing during the last decade and allergic reactions to lupine have been reported, especially in peanut‐allergic patients. The frequency and the degree of cross‐reactivity to other legumes are not known. The aim of the study was to investigate the frequency of sensitization to lupine, and in addition to pea and soy, and its clinical relevance, in peanut‐sensitized patients. Furthermore, to determine the eliciting dose (ED) for lupine using double‐blind placebo‐controlled food challenges (DBPCFC).


Clinical & Experimental Allergy | 2010

T cell responses to major peanut allergens in children with and without peanut allergy

Annebeth E. Flinterman; Suzanne G.M.A. Pasmans; C.F. den Hartog Jager; Maarten O. Hoekstra; C.A.F.M. Bruijnzeel-Koomen; Edward F. Knol; E. van Hoffen

Background T cell responses involved in peanut allergy are poorly understood.


Allergy | 2013

Components in soy allergy diagnostics: Gly m 2S albumin has the best diagnostic value in adults

R. J. B. Klemans; Edward F. Knol; Anouska D. Michelsen-Huisman; Suzanne G.M.A. Pasmans; W. de Kruijf-Broekman; Carla A.F.M. Bruijnzeel-Koomen; E. van Hoffen; André C. Knulst

Thus far, four soy allergens have been characterized. Their diagnostic value was assessed only using a case‐control design with controls not suspected of soy allergy or in a soy‐allergic population without controls. Our objective was to analyze the diagnostic value of specific immunoglobulin E (sIgE) to Gly m 2S albumin, Gly m 4, 5, and 6, and their possible relation with severity or culprit soy product.

Collaboration


Dive into the E. van Hoffen's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

C.A.F.M. Bruijnzeel-Koomen

Swiss Institute of Allergy and Asthma Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge